18 results for “BIOCON”
DSP Value Fund NFO: Should you invest?
DSP Mutual Fund has launched an NFO (New Fund Offering) for an active equity fund called the DSP Value Fund. The NFO is open from 20th Nov to 4th Dec 2020. We took a look to see if it makes sense for investors. Short Answer: Unlike market-cap based categories, there are no clearly defined rules on what makes a value fund. As a group, Value / Contra funds have struggled to beat the NIFTY over the last five years. A new fund in this category will need to demonstrate meaningful differentiation in how it picks domestic and international stocks before it can be considered a worthy addition to a portfolio Read on for our take on the DSP Value Fund NFO.
Anoop Vijaykumar25 Nov 2020Mutual Funds
How to think about picking stocks in India
What are the chances of any stock in your portfolio being a failed investment? It depends on how you define "failed investment" 30%: If it means suffering an erosion massive enough to mean significant and permanent loss of capital 47%: If it also includes stocks that fail to offer some positive return over 5+ years 53%: If it also includes stocks that fail to beat cash sitting in your savings account Here's why.
Anoop Vijaykumar8 Sept 2020Foundations
Podcast: Will Corporate Tax Cuts Fix India's Bruised Economy? (Ep-11)
1 Oct 2019Economy
Earnings Report Closing Piece : 3QFY17 : 663 Companies Till Date With Management Comments!
Aakash Agarwal23 Feb 2017Stocks
Earnings Report: 3QFY17 : 495 Companies Till Now With Management Comments
Aakash Agarwal11 Feb 2017Stocks
2016 in Review: The Top 10 Large Cap Performers!
Aakash Agarwal29 Dec 2016Stocks
EMA agrees to review Mylan and Biocon's Regulatory Submission for proposed biosimilar Pegfilgrastim
Aakash Agarwal21 Jul 2016Stocks
Biocon receives approval from Drug Controller General of India for the first ever clinical trial of a siRNA therapy
Aakash Agarwal23 Jun 2016Stocks
March 2016 Results – Alembic Pharmaceuticals, Bharti Airtel, Yes Bank and more
Aakash Agarwal27 Apr 2016StocksMisleading Reporting: Indian Pharma Company APIs are NOT Banned in the US
Deepak Shenoy4 Feb 2016GeneralOn Slack: The graveyard of corporate raiders, Saudi Life With $30 Oil, Trump and Sanders, Bill Gates Mobile Banking, Fed's Bullard, Barron’s 2016 Roundtable, Luxury tax on ICUs, Adani-Hazira Port, Pendulum Swing and more...
Gautam Jagannathan19 Jan 2016GeneralSyngene IPO: A Very Dull Analysis
Deepak Shenoy27 Jul 2015StocksBiocon Rumours of Oral Insulin Deal Push Up Stock 10%
Deepak Shenoy22 Apr 2014StocksBye Bye Apollo Tyres (For Now)
Deepak Shenoy24 Dec 2013StocksMV Chronicle: Entry Using Technicals
Deepak Shenoy25 Jul 2011FoundationsOrchid Chem: What’s Cooking?
Deepak Shenoy19 Oct 2010StocksReadings: China Raises Rates, Coal India, Bond Yields
Deepak Shenoy19 Oct 2010CommentarySo FCCBs do hurt, or do they?
Deepak Shenoy21 Oct 2008General